---
reference_id: "PMID:35837780"
title: "Aromatase deficiency caused by mutation of CYP19A1 gene: A case report."
authors:
- Li H
- Fu S
- Dai R
- Sheng Z
- Liu W
journal: Zhong Nan Da Xue Xue Bao Yi Xue Ban
year: '2022'
doi: 10.11817/j.issn.1672-7347.2022.210401
content_type: abstract_only
---

# Aromatase deficiency caused by mutation of CYP19A1 gene: A case report.
**Authors:** Li H, Fu S, Dai R, Sheng Z, Liu W
**Journal:** Zhong Nan Da Xue Xue Bao Yi Xue Ban (2022)
**DOI:** [10.11817/j.issn.1672-7347.2022.210401](https://doi.org/10.11817/j.issn.1672-7347.2022.210401)

## Content

1. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jun 28;47(6):794-800. doi: 
10.11817/j.issn.1672-7347.2022.210401.

Aromatase deficiency caused by mutation of CYP19A1 gene: A case report.

Li H(1), Fu S(2), Dai R(3), Sheng Z(3), Liu W(4).

Author information:
(1)Department of Endocrinology, First Hospital of Lanzhou University, Lanzhou 
730000. lihl19@lzu.edu.cn.
(2)Department of Endocrinology, First Hospital of Lanzhou University, Lanzhou 
730000.
(3)National Clinical Research Center for Metabolic Diseases; Department of 
Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, 
Changsha 410011, China.
(4)National Clinical Research Center for Metabolic Diseases; Department of 
Metabolism and Endocrinology, Second Xiangya Hospital, Central South University, 
Changsha 410011, China. liuwei_13510@163.com.

Aromatase deficiency (AD) is a rare autosomal recessive genetic disease caused 
by loss-of-function mutations in aromatase gene (CYP19A1), leading to congenital 
estrogen deficiency syndrome. Both mothers of AD patients during pregnancy and 
female AD fetus show virilization, while male patients are usually diagnosed in 
adulthood due to continued height increase and metabolic abnormalities. In 2019, 
a patient with AD was admitted in the Second Xiangya Hospital. The patient was a 
37-year-old adult male who continued to grow linearly after adulthood. His 
estradiol was below the measurable line, the follicle-stimulating hormone (FSH) 
increased, bone age delayed, epiphysis unfused, and the bone mass reduced. 
CYP19A1 gene detection showed that c.1093C>T, p.R365W was homozygous mutation. 
This disease is rare in clinic. Clinicians need to raise awareness of the 
disease for early diagnosis and treatment to improve the long-term prognosis of 
patients.

Publisher: 芳香化酶缺乏症(aromatase 
deficiency，AD)是一种罕见的芳香化酶基因(CYP19A1)失活突变引起的常染色体隐性遗传病，导致先天性雌激素缺乏综合征。AD患者的母亲在妊娠期以及女性胎儿出生时均可出现男性化表现，而男性患者通常在成年后因身高持续增长和代谢异常才得以诊断。2019年中南大学湘雅二医院收治了1例AD患者，该患者为37岁成年男性，成年后仍持续生长，其雌二醇低于可测线、促卵泡激素(follicle-stimulating 
hormone，FSH)升高、骨龄落后、骨骺未闭合、骨量减少，CYP19A1基因检测示c.1093C>T，p.R365W纯合子突变。该病临床较罕见，临床医生需提高对该病的认识，早期诊断和治疗，以改善患者的长期预后。.

芳香化酶缺乏症(aromatase 
deficiency，AD)是一种罕见的芳香化酶基因(CYP19A1)失活突变引起的常染色体隐性遗传病，导致先天性雌激素缺乏综合征。AD患者的母亲在妊娠期以及女性胎儿出生时均可出现男性化表现，而男性患者通常在成年后因身高持续增长和代谢异常才得以诊断。2019年中南大学湘雅二医院收治了1例AD患者，该患者为37岁成年男性，成年后仍持续生长，其雌二醇低于可测线、促卵泡激素(follicle-stimulating 
hormone，FSH)升高、骨龄落后、骨骺未闭合、骨量减少，CYP19A1基因检测示c.1093C>T，p.R365W纯合子突变。该病临床较罕见，临床医生需提高对该病的认识，早期诊断和治疗，以改善患者的长期预后。

DOI: 10.11817/j.issn.1672-7347.2022.210401
PMCID: PMC10930014
PMID: 35837780 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare that they have no conflicts 
of interest to disclose.